Trial Profile
A phase I trial of lenalidomide and paclitaxel in androgen-independent prostate cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Aug 2006
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Paclitaxel
- Indications Prostate cancer
- Focus Adverse reactions
- 02 Aug 2006 New trial record.